Neovascular age-related macular degeneration: Present and future treatment options

Eye

Volumn 15, Issue 3, 2001, Pages 424-429

  Votruba, M ^a   Gregor, Z ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANGIOGENESIS INHIBITOR; INTEGRIN; INTERFERON; THALIDOMIDE; TRIAMCINOLONE; VASCULOTROPIN;

ADULT; AGE; AGED; ARTICLE; ATROPHY; BLINDNESS; BLOOD; CENTRAL NERVOUS SYSTEM; CHOROID; CONTROLLED STUDY; DEVELOPED COUNTRY; DIET; FATIGUE; GASTROINTESTINAL SYMPTOM; GENE TARGETING; GENE THERAPY; HUMAN; INFLUENZA; LASER SURGERY; MEDICAL INFORMATION; NEUROTOXICITY; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETINA PIGMENT EPITHELIOPATHY; SCAR FORMATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0034956248     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.2001.147     Document Type: Article

References (59)

1. Age-related macular degeneration
2. Prevalence of age-related maculopathy: The Beaver Dam Eye Study
3. Laser treatments with verteporfin therapy and its potential impact on retinal practices
4. Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration
5. Utility values and age-related macular degeneration
6. Evidence-based medicine, utilities and quality of life
7. Alternative therapies in exudative age related macular degeneration
8. Treatment of senile disciform macular degeneration: A single blind randomised trial by argon laser photocoagulation
9. Argon laser photocoagulation for neovascular maculopathy after five years: Results from randomized clinical trials
10. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: Results of a randomized clinical trial
11. Laser photocoagulation of subfoveal neovascular lesions of age-related macula degeneration: Update findings from two clinical trials
12. Laser photocoagulation of juxtafoveal choroidal neovascularization: Five-year results of randomized clinical trials
13. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: The influence of initial lesion size and initial visual acuity
14. Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization
15. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization
16. Iris pigment epithelium transplantation
17. Age-related macular degeneration: A review of experimental treatments
18. Visual results after surgical removal of subfoveal choroidal neovascular membranes
19. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: Results of a prospective study
20. Human neural retinal transplantation
21. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes
22. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. I. Pilot study report number 1(2)
23. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. II. Trials pilot study report number 2
24. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration
25. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: A prospective study
26. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration
27. Complications associated with limited macular translocation
28. Expanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization
29. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials: TAP report 2
30. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials: TAP report 1
31. Transpupillary thermotherapy for age-related macular degeneration: Long-pulse photocoagulation, apoptosis and heat shock proteins
32. Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation
33. Survey of radiosensitivity in a variety of human cell strains
34. Radiosensitivity of capillary endothelium
35. Radiation retinopathy: Clinical, histological and ultrastructural correlation
36. A light microscopic and autoradiographic study of irradiated ocular wounds
37. Radiation reduced cyclooxygenase activity in cultured human endothelial cells at low doses
38. Treatment of age-related subfoveal neovascular membrane by teletherapy: A pilot study
39. Radiotherapy for choroidal neovascularisation of age-related macular degeneration: A fresh perspective
40. Age-related macular degeneration: Long-term results of radiotherapy for subfoveal neovascular membranes
41. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: One-year results of a prospective, double-masked, randomized clinical trial
42. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: Radiation versus observation
43. Randomized trial of radiation for age-related macular degeneration
44. A prospective double-masked trial on radiation therapy for neovascular age-related macular degeneration
45. Interferon-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial
46. Interferon alpha-2 in the treatment of subfoveal choroidal neovascularization
47. Thalidomide is an inhibitor of angiogenesis
48. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration
49. Exudative macular degeneration and intravitreal triamcinolone: A pilot study
50. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow-up
51. A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration: Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients
52. Laser treatment in subjects with high-risk clinical features of age-related macular degeneration: Posterior pole appearance and retinal function
53. Laser treatment in eyes with large drusen: Short-term effects seen in a pilot randomized clinical trial
54. Laser-induced drusen reduction improves visual function at 1 year
55. Therapeutic benefits of infrared (810 nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: Two-year results of a randomized pilot study
56. Lutein and zeaxanthin in the eyes, serum and diet of human subjects
57. Antioxidant vitamin and mineral supplements for age-related macular degeneration
58. Gene therapy for the eye
59. The possibility of gene therapy for the treatment of choroidal neovascularization